COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to Coronavirus disease 2019 (COVID-19), is not always confined to the respiratory tract, while patients with can develop neurological manifestations. The patients with multiple sclerosis (MS) pose challenges in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeghmousavi, Shaghayegh, Rezaei, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467844/
https://www.ncbi.nlm.nih.gov/pubmed/32895640
http://dx.doi.org/10.1007/s42399-020-00504-9
_version_ 1783578095735799808
author Sadeghmousavi, Shaghayegh
Rezaei, Nima
author_facet Sadeghmousavi, Shaghayegh
Rezaei, Nima
author_sort Sadeghmousavi, Shaghayegh
collection PubMed
description Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to Coronavirus disease 2019 (COVID-19), is not always confined to the respiratory tract, while patients with can develop neurological manifestations. The patients with multiple sclerosis (MS) pose challenges in this pandemic situation, because of the immunosuppressive medications they get and the fact that viral infections may contribute to MS exacerbation and relapses as an environmental factor in genetically predisposed individuals. Herein, possible consequences of COVID-19 which may carry for the MS patients and the underlying mechanisms of its impact are discussed.
format Online
Article
Text
id pubmed-7467844
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-74678442020-09-03 COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment Sadeghmousavi, Shaghayegh Rezaei, Nima SN Compr Clin Med Covid-19 Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to Coronavirus disease 2019 (COVID-19), is not always confined to the respiratory tract, while patients with can develop neurological manifestations. The patients with multiple sclerosis (MS) pose challenges in this pandemic situation, because of the immunosuppressive medications they get and the fact that viral infections may contribute to MS exacerbation and relapses as an environmental factor in genetically predisposed individuals. Herein, possible consequences of COVID-19 which may carry for the MS patients and the underlying mechanisms of its impact are discussed. Springer International Publishing 2020-09-03 2020 /pmc/articles/PMC7467844/ /pubmed/32895640 http://dx.doi.org/10.1007/s42399-020-00504-9 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Covid-19
Sadeghmousavi, Shaghayegh
Rezaei, Nima
COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
title COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
title_full COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
title_fullStr COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
title_full_unstemmed COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
title_short COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
title_sort covid-19 and multiple sclerosis: predisposition and precautions in treatment
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467844/
https://www.ncbi.nlm.nih.gov/pubmed/32895640
http://dx.doi.org/10.1007/s42399-020-00504-9
work_keys_str_mv AT sadeghmousavishaghayegh covid19andmultiplesclerosispredispositionandprecautionsintreatment
AT rezaeinima covid19andmultiplesclerosispredispositionandprecautionsintreatment

Ejemplares similares